======= RYBP ======= == Gene Information == * **Official Symbol**: RYBP * **Official Name**: RING1 and YY1 binding protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23429|23429]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N488|Q8N488]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RYBP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RYBP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607535|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1-like complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:25519132). Component of a PRC1-like complex that mediates monoubiquitination of histone H2A 'Lys-119' on the X chromosome and is required for normal silencing of one copy of the X chromosome in XX females. May stimulate ubiquitination of histone H2A 'Lys-119' by recruiting the complex to target sites (By similarity). Inhibits ubiquitination and subsequent degradation of TP53, and thereby plays a role in regulating transcription of TP53 target genes (PubMed:19098711). May also regulate the ubiquitin-mediated proteasomal degradation of other proteins like FANK1 to regulate apoptosis (PubMed:14765135, PubMed:27060496). May be implicated in the regulation of the transcription as a repressor of the transcriptional activity of E4TF1 (PubMed:11953439). May bind to DNA (By similarity). {ECO:0000250|UniProtKB:Q8CCI5, ECO:0000269|PubMed:11953439, ECO:0000269|PubMed:14765135, ECO:0000269|PubMed:19098711, ECO:0000269|PubMed:27060496}. |zf-RanBP| |histone H2A monoubiquitination| |histone H2A ubiquitination| |PcG protein complex| |histone monoubiquitination| |negative regulation of proteasomal ubiquitin-dependent protein catabolic process| |negative regulation of G0 to G1 transition| |histone ubiquitination| |regulation of G0 to G1 transition| |negative regulation of ubiquitin-dependent protein catabolic process| |negative regulation of proteasomal protein catabolic process| |protein monoubiquitination| |negative regulation of proteolysis involved in cellular protein catabolic process| |negative regulation of cellular protein catabolic process| |regulation of proteasomal ubiquitin-dependent protein catabolic process| |negative regulation of protein catabolic process| |regulation of ubiquitin-dependent protein catabolic process| |regulation of proteasomal protein catabolic process| |regulation of proteolysis involved in cellular protein catabolic process| |transcription corepressor activity| |regulation of cellular protein catabolic process| |negative regulation of cellular catabolic process| |negative regulation of catabolic process| |negative regulation of cell cycle process| |negative regulation of proteolysis| |histone modification| |covalent chromatin modification| |regulation of protein catabolic process| |negative regulation of cell cycle| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |protein ubiquitination| |positive regulation of cell death| |chromatin organization| |regulation of proteolysis| |regulation of cell cycle process| |protein modification by small protein conjugation| |regulation of cellular catabolic process| |negative regulation of transcription by RNA polymerase II| |apoptotic process| |protein modification by small protein conjugation or removal| |regulation of catabolic process| |negative regulation of cellular protein metabolic process| |programmed cell death| |chromosome organization| |cell death| |negative regulation of protein metabolic process| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |regulation of programmed cell death| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of cell death| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.91| |[[:results:exp4|Actinomycin-D 0.01μM R00 exp4]]|-1.86| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-1.81| |[[:results:exp34|Rotenone 20μM R00 exp34]]|-1.71| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.414| Global Fraction of Cell Lines Where Essential: N/A ^Tissue^Fraction Of Cell Lines Where Essential^ == Essentiality in NALM6 == * **Essentiality Rank**: 18795 * **Expression level (log2 read counts)**: 5.12 {{:chemogenomics:nalm6 dist.png?nolink |}}